The multiple layers of prevention science research

American Journal of Preventive Medicine

Volumn 28, Issue 5, 2005, Pages 491-495

  MacQueen, Kathleen M ^a   Cates Jr , Willard ^a  

^a FAMILY HEALTH INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT;

AWARENESS; CLINICAL RESEARCH; DRUG RESEARCH; EMERGENCY CONTRACEPTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFORMATION CENTER; INFORMATION DISSEMINATION; INFORMATION SERVICE; MEDICAL ETHICS; MEDICAL INFORMATION; PREVENTIVE HEALTH SERVICE; PRIMARY PREVENTION; REVIEW; SEXUAL TRANSMISSION;

BIOMEDICAL RESEARCH; CONSUMER PARTICIPATION; FEMALE; HEALTH POLICY; HUMANS; PREVENTIVE MEDICINE; PROGRAM DEVELOPMENT; PUBLIC HEALTH;

EID: 19344366309     PISSN: 07493797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amepre.2005.02.020     Document Type: Review

References (45)

1. Institute of Medicine The future of the public's health in the 21st century 2003 National Academies Press Washington DC
2. W. Cates Jr Prevention science the umbrella discipline Am J Prev Med 11 1995 211
3. G. Rose, D.J. Barker Epidemiology for the uninitiated experimental studies BMJ 2 1978 1687 1688
4. S.O. Aral, K.K. Holmes, N.S. Padian, W. Cates Jr Overview individual and population approaches to the epidemiology and prevention of sexually transmitted diseases and human immunodeficiency virus infection J Infect Dis 174 suppl 2 1996 S127 S133
5. Centers for Disease Control and Prevention Framework for program evaluation in public health MMWR Morb Mortal Wkly Rep 48 1999 1 40
6. D.A. Grimes, K.F. Schulz An overview of clinical research the lay of the land Lancet 359 2002 57 61
7. A. Donner Some aspects of the design and analysis of cluster randomized trials Appl Stats 47 1998 95 113
8. T. Pang, R. Sadana, S. Hanney, Z.A. Bhutta, A.A. Hyder, J. Simon Knowledge for better health a conceptual framework and foundation for health research systems Bull World Health Organ 81 2003 815 820
9. A. Burls, J. Cabello-López Research methods in public health P. Bradley A. Burls Ethics in public and community health 2000 Routledge London 135 147
10. Joint United Nations Programme on HIV/AIDS Ethical considerations in HIV preventive vaccine research 2000 Joint United Nations Programme on HIV/AIDS Geneva
11. K.M. MacQueen, K. Shapiro, Q. Abdool Karim, J. Sugarman Ethical challenges in international HIV prevention research Accountability Res 11 2004 49 61
12. International AIDS Vaccine Initiative When will an AIDS vaccine be found? 2004 Available at: www.iavi.org/viewfile.cfm?fid=229.
13. AIDS Vaccine Advocacy Coalition AIDS vaccine trials getting the global house in order 2004 AIDS Vaccine Advocacy Coalition New York
14. Global Campaign for Microbicides Annual report, March 2001 to March 2002 2002 Global Campaign for Microbicides Washington DC
15. L.W. Green, S.L. Mercer Can public health researchers and agencies reconcile the push from funding bodies and the pull from communities? Am J Public Health 91 2001 1926 1929
16. N.S. Sung, W.F. Crowley Jr, M. Genel Central challenges facing the national clinical research enterprise JAMA 289 2003 1278 1287
17. B.N. Bartholow, K.M. MacQueen, J.M. Douglas Jr, S. Buchbinder, D. McKirnan, F.N. Judson Assessment of the changing willingness to participate in phase III HIV vaccine trials among men who have sex with men J Acquir Immune Defic Syndr Hum Retrovirol 16 1997 108 115
18. B.A. Koblin, S. Avrett, P.E. Taylor, C.E. Stevens Willingness to participate in HIV-1 vaccine efficacy trials and the effect of media events among gay and bisexual men in New York City Project ACHIEVE J Acquir Immune Defic Syndr Hum Retrovirol 15 1997 165 171
19. R.P. Strauss, S. Sengupta, S. Kegeles Willingness to volunteer in future preventive HIV vaccine trials issues and perspectives from three U.S. communities J Acquir Immune Defic Syndr 26 2001 63 71
20. D.P. Francis, W.L. Heyward, V. Popovic Candidate HIV/AIDS vaccines lessons learned from the world's first phase III efficacy trials AIDS 17 2003 147 156
21. J. Brooks-Gunn, M.J. Rotheram-Borus Rights to privacy in research adolescents versus parents Ethics Behav 4 1994 109 121
22. R.J. Levine Adolescents as research subjects without permission of their parents or guardians ethical considerations J Adolesc Health 17 1995 287 297
23. E. Mills, C. Cooper, G. Guyatt Barriers to participating in an HIV vaccine trial a systematic review AIDS 18 2004 2235 2242
24. C. Elias, C. Coggins Acceptability research on female-controlled barrier methods to prevent heterosexual transmission of HIV Where have we been? Where are we going? J Womens Health Gend Based Med 10 2001 163 173
25. National Bioethics Advisory Commission Ethical and policy issues in international research clinical trials in developing countries 2001 National Bioethics Advisory Commission Bethesda MD
26. A. Philpott, D. Maher, H. Grosskurth Translating HIV/AIDS research findings into policy lessons from a case study of 'the Mwanza trial' Health Policy Plann 17 2002 196 201
27. J.A. Alaii, H.W. van den Borne, S.P. Kachur Community reactions to the introduction of permethrin-treated bed nets for malaria control during a randomized controlled trial in western Kenya Am J Trop Med Hyg 68 suppl 4 2003 128 136
28. S.C. Quinn Protecting human subjects the role of community advisory boards Am J Public Health 94 2004 918 922
29. G.B. Melton, R.J. Levine, G.P. Koocher, R. Rosenthal, W.C. Thompson Community consultation in socially sensitive research Lessons from clinical trials of treatments for AIDS Am Psychol 43 1988 573 581
30. A. Ammerman, G. Corbie-Smith, D.M. St George, C. Washington, B. Weathers, B. Jackson-Christian Research expectations among African American church leaders in the PRAISE! project a randomized trial guided by community-based participatory research Am J Public Health 93 2003 1720 1727
31. L.R. O'Fallon, A. Dearry Community-based participatory research as a tool to advance environmental health sciences Environ Health Perspect 110 suppl 2 2002 155 159
32. C. Woodsong Covert use of topical microbicides implications for acceptability and use Perspect Sex Reprod Health 36 2004 127 131
33. L.J. Severy Acceptability as a critical component of clinical trials L.J. Severy W.B. Miller Advances in population psychosocial perspectives, vol 3. 1999 Jessica Kingsley Publishers London 103 122
34. D.J. Toobert, L.A. Strycker, R.E. Glasgow, M. Barrera, J.D. Bagdade Enhancing support for health behavior change among women at risk for heart disease the Mediterranean Lifestyle Trial Health Educ Res 17 2002 574 578
35. L.Y. Wang, M. Davis, L. Robin, J. Collins, K. Coyle, E. Baumler Economic evaluation of Safer Choices a school-based human immunodeficiency virus, other sexually transmitted diseases, and pregnancy prevention program Arch Pediatr Adolesc Med 154 2000 1017 1024
36. J.S. Burgers, J.J. van Everdingen Beyond the evidence in clinical guidelines Lancet 364 2004 392 393
37. D.A. Grimes, E.G. Raymond, B. Scott Jones Emergency contraception over-the-counter the medical and legal imperatives Obstet Gynecol 98 2001 151 155
38. E.T. Robinson, M. Metcalf-Whittaker, R. Rivera Introducing emergency contraceptive services communications strategies and the role of women's health advocates Int Fam Plann Perspect 22 1996 71 75
39. A. Shilkik Campaign launched to tell physicians, public about emergency contraception JAMA 278 1997 101 102
40. J.M. Drazen, M.F. Greene, A.J.J. Wood The FDA, politics, and Plan B N Engl J Med 350 2004 1561 1562
41. P. Harrison, Z. Rosenberg, J. Bowcut Topical microbicides for disease prevention status and challenges Clin Infect Dis 36 2004 1290 1294
42. C. Mauck, Z. Rosenberg, L. Van Damme International Working Group on Microbicides. Recommendations for the clinical development of topical microbicides: an update AIDS 15 2001 857 868
43. R.E. Roddy, L. Zekeng, K.A. Ryan, U. Tamoufe, K.G. Tweedy Effect of nonoxynol-9 gel on urogenital gonorrhea and chlamydial infection a randomized controlled trial JAMA 287 2002 1117 1122
44. R.E. Roddy, L. Zekeng, K.A. Ryan, U. Tamoufe, S.S. Weir, E.L. Wong A controlled trial of nonoxynol 9 film to reduce male-to-female transmission of sexually transmitted diseases N Engl J Med 339 1998 504 510
45. L. Van Damme, G. Ramjee, M. Alary Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers a randomised controlled trial Lancet 360 2002 971 977